Loading market data...

Senores Pharmaceuticals IPO

Specialty Pharma/Generic - Listed on 30 December 2024

+53.5% listing gain
Issue Price (Upper)
Rs 391
Listing Price
Rs 600
Closing Price (NSE)
Rs 557.05
Total Subscription
93.41x

Senores Pharmaceuticals IPO listing summary

Senores Pharmaceuticals (Specialty Pharma/Generic) closed its IPO window in 2024 and listed on NSE and BSE on 30 December 2024 at an upper band issue price of Rs 391, opening at Rs 600 for a listing gain of +53.5% and closing day one at Rs 557.05 (+42.5% on closing basis). The IPO was subscribed 93.41x overall - QIB 94.66x, HNI/NII 96.11x, Retail 89.22x. The total issue size was Rs 582.11 Cr (Fresh Issue Rs 500 Cr, OFS Rs 82.11 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+53.45%
Listing Gain (Close)
+42.47%
Day Change After Listing
-10.98%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB94.66x
HNI / NII96.11x
Retail89.22x
Overall93.41x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 11.78x
Day 213.93x
Day 3 (Final)93.41x

Senores Pharmaceuticals IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 150+63.94%
Day 2Rs 150+61.38%
Day 3Rs 150+61.38%
Day 4Rs 175+56.78%
Day 5Rs 222+56.78%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
56.8%-63.9%
IPOGyani AI Prediction
-
Actual Listing Gain
+53.5%

Issue & financials

Issue SizeRs 582.11 Cr
Fresh IssueRs 500 Cr
OFSRs 82.11 Cr
IPO PE37.60
Peer / Sector PE34.48
PE vs Sector Ratio1.09
Latest EBITDA (Cr)20.70
Debt / Equity1.07

Market context at listing

How the broader market moved around the Senores Pharmaceuticals IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return-2.90%
Nifty 1W Return-2.43%
Nifty 1M Return+2.12%
Nifty during IPO window-0.83%

Senores Pharmaceuticals IPO - FAQs

What was the listing gain of Senores Pharmaceuticals IPO?

Senores Pharmaceuticals IPO listed at +53.5% versus the upper issue price of Rs 391 on 30 December 2024.

How many times was Senores Pharmaceuticals IPO subscribed?

Senores Pharmaceuticals IPO was subscribed 93.41x overall. QIB portion was subscribed 94.66x, HNI / NII 96.11x and Retail 89.22x.

What was the IPO GMP for Senores Pharmaceuticals?

IPO GMP started at Rs 150 on Day 1 and moved to Rs 222 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2024

Browse listed IPOs by year